Novo Nordisk Establishes Type 1 Diabetes R&D Center in Seattle MarketWatch (press release) 23, 2012 /PRNewswire via COMTEX/ — Novo Nordisk /quotes/zigman/160794/quotes/nls/nvo NVO -0.65% announced today that the company will establish a type 1 diabetes research and development center in Seattle, Wash., US The new center will combine Novo … La Jolla Institute Scientist Takes Quest to Conquer Type 1 Diabetes to the … Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for … |
Share this:
Related posts:
- Amylin’s Byetta Has Better Formulary Positioning Than Novo Nordisk’s Victoza … – MarketWatch (press release)
- Novo Nordisk Q3 beats f’casts as Victoza shines – Reuters
- Novo Nordisk Q3 beats forecasts, outlook upbeat – Reuters
- Novo Nordisk Q3 beats forecasts, outlook upbeat – Reuters
- He’s a Type 1 on TV and in Real Life – Diabetes Health (press release)
admin
Twitter